BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,
John E Shulze, CTO Biosensors International Inc Drug Application in Stent Technology: How to Diversify?
BIOSENSORS-CLINICAL UPDATE “LEADERS AND BEYOND” John E Shulze, CTO BIOSENSORS INTERNATIONAL GROUP Jan 29, 2010.
Volker Klauss, MD Patrick W. Serruys, Simon Wandel, Pawel Buszman,
